There was a trend towards shorter OS in ERCC1-positive compared to ERCC1-negative patients that did not reach statistical significance (median OS of 29.7 months (95% CI, 10.9–48.5 vs. 36.8, 95% CI, 0.001–102 months; log-rank p = 0.38).
← all excerpts
Baseline and Kinetic Circulating Tumor Cell Counts Are Prognostic Factors in a Prospective Study of Metastatic Colorectal Cancer.
1
0.3800
0.3800